Lumida
/CLYM
⌘K
Climb Bio Inc

Climb Bio Inc

CLYM
$14.59USD↓-3.06%-0.46 today

MARKET CAP

838.0M

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$14 – $15

52W RANGE

$2
$18

AI Summary

Stalk
Buy NowMedium

Recent rapid advances in a Lockout Rally confirm strong institutional urgency and forced participation, justifying participation now despite overbought conditions. The medium-term uptrend remains intact with rising EMAs and higher highs, supported by pattern continuation. Short-term extension is offset by the Lockout Rally override, allowing a Buy Now posture. Key risks include overbought RSI and potential shallow pullbacks if forced demand subsides.

  • ↑Strong momentum indicates sustained upward price trends
  • ↑Dividend yield of 1.43% underpins reliable shareholder returns
  • ↓Negative earnings yield and poor profitability hinder return generation
Full analysis →
Sales, Adj.
No data
Gross Profit, Adj.
No data
EBITDA, Adj.
EBIT
Net Income